DexCom, Inc.
US ˙ NasdaqGS ˙ US2521311074

SecurityDXCM / DexCom, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Parallel Advisors, LLC ownership in DXCM / DexCom, Inc.

On June 2, 2026 - Parallel Advisors, LLC filed a 13F-HR/A form disclosing ownership of 0 shares of DexCom, Inc. (US:DXCM) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,458 shares of DexCom, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (DXCM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DXCM / DexCom, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F/A-1 DEXCOM INC COM Stock 252131107 0 -2,458 -100.00 0 -100.00
2026-02-11 2025-12-31 13F DEXCOM INC COM Stock 252131107 2,458 826 50.61 163 49.54 0.0030
2025-11-13 2025-09-30 13F DEXCOM INC COM Stock 252131107 1,632 -427 -20.74 110 -39.11 0.0020
2025-07-08 2025-06-30 13F DEXCOM INC COM Stock 252131107 2,059 -458 -18.20 180 4.68 0.0036
2025-04-08 2025-03-31 13F DEXCOM INC COM Stock 252131107 2,517 -195 -7.19 172 -18.57 0.0039
2025-02-10 2024-12-31 13F DEXCOM INC COM Stock 252131107 2,712 735 37.18 211 59.09 0.0047
2024-11-13 2024-09-30 13F DEXCOM INC COM Stock 252131107 1,977 -2,047 -50.87 133 -71.05 0.0031
2024-08-08 2024-06-30 13F DEXCOM INC COM Stock 252131107 4,024 -108 -2.61 456 -20.42 0.0117
2024-05-06 2024-03-31 13F DEXCOM INC COM Stock 252131107 4,132 525 14.56 573 28.19 0.0155
2024-02-12 2023-12-31 13F DEXCOM INC COM Stock 252131107 3,607 1,189 49.17 448 98.67 0.0133
2024-05-20 2023-09-30 13F/A-1 DEXCOM INC COM Stock 252131107 2,418 -396 -14.07 226 -37.67 0.0075
2023-11-14 2023-09-30 13F DEXCOM INC COM Stock 252131107 2,418 -396 226 0.0075
2024-05-20 2023-06-30 13F/A-1 DEXCOM INC COM Stock 252131107 2,814 65 2.36 362 13.17 0.0116
2023-08-04 2023-06-30 13F DEXCOM INC COM Stock 252131107 2,814 65 362 0.0116
2024-05-20 2023-03-31 13F/A-1 DEXCOM INC COM Stock 252131107 2,749 -378 -12.09 319 -9.89 0.0108
2023-04-25 2023-03-31 13F DEXCOM INC COM Stock 252131107 2,749 -378 319 0.0108
2023-02-06 2022-12-31 13F DEXCOM INC COM Stock 252131107 3,127 764 32.33 354 86.32 0.0154
2022-11-10 2022-09-30 13F DEXCOM INC COM Stock 252131107 2,363 679 40.32 190 50.79 0.0087
2022-08-01 2022-06-30 13F DEXCOM INC COM Stock 252131107 1,684 1,097 186.88 126 -58.69 0.0058
2022-04-28 2022-03-31 13F DEXCOM INC COM Stock 252131107 587 -14 -2.33 305 -5.57 0.0121
2022-01-20 2021-12-31 13F DEXCOM INC COM Stock 252131107 601 25 4.34 323 2.54 0.0120
2021-11-02 2021-09-30 13F/A-1 DEXCOM INC COM Stock 252131107 576 141 32.41 315 69.35 0.0127
2021-08-06 2021-06-30 13F DEXCOM INC COM Stock 252131107 435 87 25.00 186 48.80 0.0079
2021-04-23 2021-03-31 13F DEXCOM INC COM Stock 252131107 348 -118 -25.32 125 -27.33 0.0059
2021-02-02 2020-12-31 13F DEXCOM INC COM Stock 252131107 466 -239 -33.90 172 -40.89 0.0093
2020-10-27 2020-09-30 13F DEXCOM INC COM Stock 252131107 705 396 128.16 291 132.80 0.0180
2020-07-16 2020-06-30 13F DEXCOM INC COM Stock 252131107 309 -36 -10.43 125 35.87 0.0082
2020-04-27 2020-03-31 13F DEXCOM INC COM Stock 252131107 345 -28 -7.51 92 12.20 0.0074
2020-01-30 2019-12-31 13F DEXCOM INC COM Stock 252131107 373 132 54.77 82 127.78 0.0062
2019-11-01 2019-09-30 13F DEXCOM INC COM Stock 252131107 241 30 14.22 36 12.50 0.0031
2019-08-05 2019-06-30 13F DEXCOM INC COM Stock 252131107 211 0 0.00 32 28.00 0.0031
2019-05-01 2019-03-31 13F DEXCOM INC COM Stock 252131107 211 0 0.00 25 0.00 0.0028
2019-02-05 2018-12-31 13F DEXCOM INC COM Stock 252131107 211 0 0.00 25 -16.67 0.0035
2018-11-01 2018-09-30 13F DEXCOM INC COM Stock 252131107 211 0 0.00 30 50.00 0.0037
2018-07-30 2018-06-30 13F DEXCOM INC COM Stock 252131107 211 73 52.90 20 100.00 0.0029
2018-05-08 2018-03-31 13F DEXCOM INC COM Stock 252131107 138 27 24.32 10 66.67 0.0016
2018-02-13 2017-12-31 13F DEXCOM INC COM Stock 252131107 111 0 0.00 6 0.00 0.0010
2017-11-15 2017-09-30 13F/A-1 DEXCOM INC COM Stock 252131107 111 13 13.27 6 -14.29 0.0010
2017-08-07 2017-06-30 13F DEXCOM INC COM Stock 252131107 98 -9 -8.41 7 -12.50 0.0013
2017-05-12 2017-03-31 13F/A-1 DEXCOM INC COM Stock 252131107 107 89 494.44 8 700.00 0.0016
2017-05-12 2017-03-31 13F DEXCOM INC COM Stock 252131107 107 8
2017-02-14 2016-12-31 13F DEXCOM INC COM Stock 252131107 18 18 1 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F DEXCOM INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F DEXCOM INC COM Stock Call 435 186 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.